0001415889-24-004452.txt : 20240220
0001415889-24-004452.hdr.sgml : 20240220
20240220181448
ACCESSION NUMBER: 0001415889-24-004452
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240215
FILED AS OF DATE: 20240220
DATE AS OF CHANGE: 20240220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bender Jeremy
CENTRAL INDEX KEY: 0001863107
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40431
FILM NUMBER: 24655501
MAIL ADDRESS:
STREET 1: 395 OYSTER POINT BLVD.
STREET 2: SUITE 217
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Day One Biopharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001845337
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 832415215
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 SIERRA POINT PARKWAY, SUITE 501
CITY: BRISBANE
STATE: CA
ZIP: 94005
BUSINESS PHONE: 650 484-0899
MAIL ADDRESS:
STREET 1: 2000 SIERRA POINT PARKWAY, SUITE 501
CITY: BRISBANE
STATE: CA
ZIP: 94005
FORMER COMPANY:
FORMER CONFORMED NAME: Day One Biopharmaceuticals Holding Co LLC
DATE OF NAME CHANGE: 20210209
4
1
form4-02202024_110237.xml
X0508
4
2024-02-15
0001845337
Day One Biopharmaceuticals, Inc.
DAWN
0001863107
Bender Jeremy
2000 SIERRA POINT PARKWAY, SUITE 501
BRISBANE
CA
94005
true
true
false
false
CHIEF EXECUTIVE OFFICER
0
Common Stock
2024-02-15
4
M
0
3562
A
712991
D
Common Stock
2024-02-15
4
M
0
4750
A
717741
D
Common Stock
2024-02-15
4
M
0
11687
A
729428
D
Common Stock
2024-02-16
4
S
0
7615
15.2481
D
721813
D
Common Stock
221837
I
See footnote
Common Stock
300025
I
See footnote
Common Stock
251636
I
See footnote
Common Stock
270226
I
See footnote
Restricted Stock Unit (RSU)
2024-02-15
4
M
0
3562
0
D
Common Stock
3562
24942
D
Restricted Stock Unit (RSU)
2024-02-15
4
M
0
4750
0
D
Common Stock
4750
52250
D
Restricted Stock Unit (RSU)
2024-02-15
4
M
0
11687
0
D
Common Stock
11687
175313
D
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement for no consideration.
The sale of shares is for the sole purpose of covering the Reporting Person's tax liability with respect to the settlement of RSUs.
Represents shares held by The Jeremy Bender 2022 Grantor Retained Annuity Trust under Irrevocable Trust Agreement dated March 29, 2022 of which the Reporting Person is trustee.
Represents shares held by The Jeremy Bender 2023 Grantor Retained Annuity Trust dated June 27, 2023.
Represents shares held by The Melissa Bender 2022 Grantor Retained Annuity Trust under Irrevocable Trust Agreement dated March 29, 2022
of which the Reporting Person's spouse is trustee.
Represents shares held by The Melissa Bender 2023 Grantor Retained Annuity Trust, dated June 27, 2023.
The RSUs will vest as to 1/16th of the total award in quarterly installments on February 15, May 15, August 15 and November 15, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
/s/ Charles N. York II, as Attorney-in-Fact
2024-02-20